![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Zeng Xiao-Hua
Publisher: Springer Publishing Company
ISSN: 0167-6806
Source: Breast Cancer Research and Treatment, Vol.125, Iss.3, 2011-02, pp. : 715-727
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Holm Neal Abreo Fleurette Johnson Lester Li Benjamin Chu Quyen
Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical implications of Ezrin and CD44 coexpression in breast cancer
Oncology Reports, Vol. 30, Iss. 4, 2013-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Vimentin DNA methylation predicts survival in breast cancer
Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Breast Cancer Outcomes and Micrometastatic Disease
Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Li Shunrong Liu Jieqiong Yang Yaping Zeng Yunjie Deng Heran Jia Haixia Li Qian Feng Huiyi Li Yangyang Song Erwei Liu Qiang Su Fengxi
Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 4, 2014-04 ,pp. :